Durata Therapeutics (NASDAQ:
DRTX) dipped 11.19% to $15.00 in pre-market trading. Durata Therapeutics confirmed the FDA approval of Dalvance to treat skin infections.
JinkoSolar Holding Co (NYSE:
JKS) shares fell 9.13% to $23.50 in pre-market trading after the company reported weaker-than-expected first-quarter earnings.
Pinnacle Foods (NYSE:
PF) dropped 6.88% to $30.98 in pre-market trading on proposed Pilgrim's Pride (NYSE:
PPC) acquisition of Hilshire (NYSE:
HSH).
Staples (NASDAQ:
SPLS) shares dropped 2.15% to $11.40 in pre-market trading after the company named Frank Bifulco as Executive Vice President, Marketing. Analysts at Goldman Sachs downgraded Staples from Neutral to Sell and lowered the target price from $11.50 to $11.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
